Cargando…
The Therapeutic Index as Indicated by Efficacy/Safety Ratio May Be Primarily Assessed by Meta-Analysis of the Efficacy of ICS Combination Therapy for COPD [Letter]
Autor principal: | Teramoto, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234182/ https://www.ncbi.nlm.nih.gov/pubmed/35769224 http://dx.doi.org/10.2147/COPD.S373924 |
Ejemplares similares
-
Efficacy of ICS versus Non-ICS Combination Therapy in COPD: A Meta-Analysis of Randomised Controlled Trials
por: Ding, Yanling, et al.
Publicado: (2022) -
Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
por: Oh, Yeon-Mok
Publicado: (2017) -
The Quantitative Computed Tomography Techniques are Alternate Modalities of Assessing the Disease Profile of COPD Instead of Pulmonary Function Testing Under COVID-19 Pandemic [Letter]
por: Teramoto, Shinji
Publicado: (2022) -
ICS and COPD: Time to clear the air
por: Ford, Paul A, et al.
Publicado: (2009) -
Efficacy and Safety of Roflumilast in Korean Patients with COPD
por: Lee, Jae Seung, et al.
Publicado: (2016)